help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scaglione-Sewell, B. A.
Right arrow Articles by Brasitus, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scaglione-Sewell, B. A.
Right arrow Articles by Brasitus, T. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*1,25-DIHYDROXYCHOLECALCIFEROL
Endocrinology Vol. 141, No. 11 3931-3939
Copyright © 2000 by The Endocrine Society


ARTICLES

A Vitamin D3 Analog Induces a G1-Phase Arrest in CaCo-2 Cells by Inhibiting Cdk2 and Cdk6: Roles of Cyclin E, p21Waf1, and p27Kip11

B. A. Scaglione-Sewell, M. Bissonnette, S. Skarosi, C. Abraham and T. A. Brasitus

Gastroenterology Section, Department of Medicine, The University of Chicago, Chicago, Illinois 60637

Address all correspondence and requests for reprints to: T. A. Brasitus, Gastroenterology Section, Department of Medicine, The University of Chicago, MC4076, 5841 South Maryland Avenue, Chicago Illinois 60637. E-mail: tbrasitu{at}medicine.bsd.uchicago.edu

Previous studies by our laboratory have shown that a noncalcemic fluorinated analog of 1{alpha},25-dihydroxyvitamin D3, 1{alpha},25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholcalciferol (F6-D3), significantly reduced the frequency of colonic adenomas and completely abolished the development of colonic adenocarcinomas in rats treated with azoxymethane. The mechanisms involved in this analog’s chemopreventive actions, however, remain unclear. In the present study, we now show that although both 1{alpha},25-dihydroxyvitamin D3 and F6-D3 inhibited the proliferation of CaCo-2 cells, a human colonic adenocarcinoma cell line, by increasing their doubling times, only F6-D3 caused an arrest of these cells in the G1 phase of their cell cycle. This arrest was accompanied by an increase in the expression of the cyclin-dependent kinase (cdk) inhibitor proteins, p21Waf1 and p27Kip1, which served to decrease the activity of cyclin-dependent kinase 2 and cyclin-dependent kinase 6, whereas the expression and phosphorylation of pRB were unchanged. In contrast to the increased expression of these cdk inhibitors, the expression of cyclin E was decreased, which further inhibited the activity of cyclin-dependent kinase 2. Collectively, the inhibition of these cyclin-dependent kinases served to arrest the CaCo-2 cells, independent of changes in pRB. Furthermore, antibody neutralization studies suggest that transforming growth factor-ß may mediate the coassociations between cdk2 and p27Kip1 and cyclin E induced by F6-D3. These data indicate that cell cycle arrest may, at least in part, underlie the chemopreventive actions of F6-D3 observed in the azoxymethane model of colon cancer. Furthermore, if the antiproliferative action observed in CaCo-2 cells also occurs in human colonic epithelium, F6-D3 may have chemopreventive potential against human colon cancer, as well.




This article has been cited by other articles:


Home page
Anticancer ResHome page
B. NURNBERG, S. GRABER, B. GARTNER, J. GEISEL, C. PFOHLER, D. SCHADENDORF, W. TILGEN, and J. REICHRATH
Reduced Serum 25-Hydroxyvitamin D Levels in Stage IV Melanoma Patients
Anticancer Res, September 1, 2009; 29(9): 3669 - 3674.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. Ng, J. A. Meyerhardt, K. Wu, D. Feskanich, B. W. Hollis, E. L. Giovannucci, and C. S. Fuchs
Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer
J. Clin. Oncol., June 20, 2008; 26(18): 2984 - 2991.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. G. Fakih, D. L. Trump, J. R. Muindi, J. D. Black, R. J. Bernardi, P. J. Creaven, J. Schwartz, M. G. Brattain, A. Hutson, R. French, et al.
A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors
Clin. Cancer Res., February 15, 2007; 13(4): 1216 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
F. Taghizadeh, M. J. Tang, and I. T. Tai
Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy
Mol. Cancer Ther., January 1, 2007; 6(1): 309 - 317.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. Martin-Venegas, S. Roig-Perez, R. Ferrer, and J. J. Moreno
Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation
J. Lipid Res., July 1, 2006; 47(7): 1416 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. T. Jacobs, M. R. Haussler, and M. E. Martinez
Vitamin D Activity and Colorectal Neoplasia: A Pathway Approach to Epidemiologic Studies
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2061 - 2063.
[Full Text] [PDF]


Home page
J. Nutr.Home page
D. M. Harris and V. L. W. Go
Vitamin D and Colon Carcinogenesis
J. Nutr., December 1, 2004; 134(12): 3463S - 3471S.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. J. Lucas, J. Domenico, and E. W. Gelfand
Cyclin-Dependent Kinase 6 Inhibits Proliferation of Human Mammary Epithelial Cells
Mol. Cancer Res., February 1, 2004; 2(2): 105 - 114.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. K. Wali, S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, J. Hart, J. Wang, M. Wen, A. Ramaswamy, L. Joseph, et al.
Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1653 - 1662.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Galbiati, L. Polastri, S. Gregori, M. Freschi, M. Casorati, U. Cavallaro, P. Fiorina, F. Bertuzzi, A. Zerbi, G. Pozza, et al.
Antitumorigenic and Antiinsulinogenic Effects of Calcitriol on Insulinoma Cells and Solid {beta}-Cell Tumors
Endocrinology, October 1, 2002; 143(10): 4018 - 4030.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Chen, B. H. Davis, M. D. Sitrin, T. A. Brasitus, and M. Bissonnette
Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3
Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G864 - G874.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society